Jeremy Grantham Dr Reddys Laboratories LTD Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 109,647 shares of RDY stock, worth $1.72 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

109,647

Previous 165,217 33.63%

Holding current value

$1.72 Million

Previous $12.6 Million 30.79%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$75.41 - $84.21 $4.19 Million - $4.68 Million	-55,570 Reduced 33.63%	109,647 $8.71 Million
Q2 2024 Aug 13, 2024	SELL	$68.26 - $76.19 $11.8 Million - $13.2 Million	-173,562 Reduced 51.23%	165,217 $12.6 Million
Q1 2024 May 14, 2024	BUY	$67.36 - $77.59 $649,821 - $748,510	9,647 Added 2.93%	338,779 $24.8 Million
Q4 2023 Feb 13, 2024	BUY	$64.27 - $69.9 $5.04 Million - $5.48 Million	78,344 Added 31.24%	329,132 $22.9 Million
Q3 2023 Nov 13, 2023	BUY	$61.9 - $72.77 $5 Million - $5.88 Million	80,784 Added 47.52%	250,788 $16.8 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $5.23 Million - $6.19 Million	98,004 Added 136.12%	170,004 $10.7 Million
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $2.12 Million - $2.33 Million	41,000 Added 132.26%	72,000 $4.1 Million
Q4 2022 Feb 13, 2023	BUY	$51.15 - $57.45 $1.34 Million - $1.5 Million	26,100 Added 532.65%	31,000 $1.6 Million
Q3 2022 Nov 10, 2022	BUY	$49.9 - $57.32 $244,510 - $280,868	4,900 New	4,900 $256,000
Q1 2022 May 13, 2022	SELL	$48.27 - $65.25 $260,658 - $352,350	-5,400 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$59.5 - $67.25 $5.01 Million - $5.66 Million	-84,205 Reduced 93.97%	5,400 $353,000
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $4.12 Million - $5.16 Million	-68,503 Reduced 43.33%	89,605 $5.84 Million
Q2 2021 Aug 12, 2021	SELL	$62.12 - $74.2 $7.67 Million - $9.16 Million	-123,400 Reduced 43.84%	158,108 $11.6 Million
Q1 2021 May 13, 2021	SELL	$57.98 - $73.08 $7.48 Million - $9.43 Million	-129,000 Reduced 31.42%	281,508 $17.3 Million
Q4 2020 Feb 12, 2021	SELL	$62.61 - $71.29 $2.06 Million - $2.35 Million	-32,900 Reduced 7.42%	410,508 $29.3 Million
Q3 2020 Nov 13, 2020	SELL	$51.39 - $72.41 $349,452 - $492,388	-6,800 Reduced 1.51%	443,408 $30.8 Million
Q2 2020 Aug 13, 2020	SELL	$39.55 - $54.65 $5.88 Million - $8.12 Million	-148,600 Reduced 24.82%	450,208 $23.9 Million
Q1 2020 May 14, 2020	BUY	$34.75 - $45.85 $2.19 Million - $2.89 Million	63,100 Added 11.78%	598,808 $24.2 Million
Q4 2019 Feb 13, 2020	BUY	$36.66 - $41.78 $2.47 Million - $2.81 Million	67,300 Added 14.37%	535,708 $21.7 Million
Q3 2019 Nov 13, 2019	SELL	$34.82 - $39.26 $3.71 Million - $4.19 Million	-106,600 Reduced 18.54%	468,408 $17.7 Million
Q2 2019 Aug 13, 2019	BUY	$36.05 - $42.76 $623,665 - $739,748	17,300 Added 3.1%	575,008 $21.5 Million
Q1 2019 May 14, 2019	BUY	$35.77 - $40.57 $704,669 - $799,229	19,700 Added 3.66%	557,708 $22.6 Million
Q4 2018 Feb 13, 2019	BUY	$31.89 - $38.44 $4.89 Million - $5.89 Million	153,300 Added 39.85%	538,008 $20.3 Million
Q3 2018 Nov 14, 2018	BUY	$29.25 - $36.73 $10.1 Million - $12.7 Million	346,008 Added 894.08%	384,708 $13.3 Million
Q2 2018 Aug 14, 2018	SELL	$28.49 - $35.06 $34,188 - $42,072	-1,200 Reduced 3.01%	38,700 $1.25 Million
Q1 2018 May 15, 2018	BUY	$31.93 - $39.54 $906,812 - $1.12 Million	28,400 Added 246.96%	39,900 $1.3 Million
Q4 2017 Feb 14, 2018	BUY	$34.15 - $37.62 $146,845 - $161,766	4,300 Added 59.72%	11,500 $432,000
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $15,055 - $18,860	500 Added 7.46%	7,200 $257,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,700	6,700 $282,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account